eXoZymes (EXOZ) Proxy filing summary

Executive summary

• Annual meeting scheduled for November 13, 2026, to be held virtually; shareholders will vote on director elections and auditor ratification.

• Proxy materials, including the 2025 Annual Report, are distributed via mail and online access; voting can be done by internet, phone, or mail.

• Record date for voting is September 15, 2026; quorum requires a majority of outstanding shares.

Voting matters and shareholder proposals

• Shareholders will elect six directors for a one-year term and ratify RBSM LLP as the independent auditor for 2026.

• Board recommends voting FOR all director nominees and FOR auditor ratification.

• Shareholder proposals for the 2027 meeting must be submitted by July 16, 2027, for inclusion in the next proxy statement.

Board of directors and corporate governance

• Board consists of six members, with a majority being independent as per Nasdaq rules.

• Chairman and CEO roles are separated; Christopher Marlett serves as Chairman.

• Board committees include Audit, Compensation, and Nominating, each composed of independent directors.

• Directors are encouraged to attend annual meetings; all attended at least 75% of meetings in 2025.

• Code of business conduct and insider trading policies are in place.

• Directors and officers are covered by indemnification agreements and liability insurance.